Tunicamycin is widely used as a research tool to block N-linked glycosylation, to verify whether the band shift was caused by a change in the glycans, tunicamycin was used as a positive control and ALG10 was knocked down in CRC cells. Here, ALG10 is linked to colorectal carcinoma.